XML 41 R11.htm IDEA: XBRL DOCUMENT v3.3.1.900
Fair Value Measurement
12 Months Ended
Dec. 31, 2015
Fair Value Disclosures [Abstract]  
Fair Value Measurement
Fair value measurement
JPMorgan Chase carries a portion of its assets and liabilities at fair value. These assets and liabilities are predominantly carried at fair value on a recurring basis (i.e., assets and liabilities that are measured and reported at fair value on the Firm’s Consolidated balance sheets). Certain assets (e.g., certain mortgage, home equity and other loans where the carrying value is based on the fair value of the underlying collateral), liabilities and unfunded lending-related commitments are measured at fair value on a nonrecurring basis; that is, they are not measured at fair value on an ongoing basis but are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment).
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is based on quoted market prices, where available. If listed prices or quotes are not available, fair value is based on models that consider relevant transaction characteristics (such as maturity) and use as inputs observable or unobservable market parameters, including but not limited to yield curves, interest rates, volatilities, equity or debt prices, foreign exchange rates and credit curves. Valuation adjustments may be made to ensure that financial instruments are recorded at fair value, as described below.
The level of precision in estimating unobservable market inputs or other factors can affect the amount of gain or loss recorded for a particular position. Furthermore, while the Firm believes its valuation methods are appropriate and consistent with those of other market participants, the methods and assumptions used reflect management judgment and may vary across the Firm’s businesses and portfolios.
The Firm uses various methodologies and assumptions in the determination of fair value. The use of different methodologies or assumptions by other market participants compared with those used by the Firm could result in a different estimate of fair value at the reporting date.
Valuation process
Risk-taking functions are responsible for providing fair value estimates for assets and liabilities carried on the Consolidated balance sheets at fair value. The Firm’s valuation control function, which is part of the Firm’s Finance function and independent of the risk-taking functions, is responsible for verifying these estimates and determining any fair value adjustments that may be required to ensure that the Firm’s positions are recorded at fair value. In addition, the firmwide Valuation Governance Forum (“VGF”) is composed of senior finance and risk executives and is responsible for overseeing the management of risks arising from valuation activities conducted across the Firm. The VGF is chaired by the Firmwide head of the valuation control function (under the direction of the Firm’s Chief Financial Officer (“CFO”)), and includes sub-forums covering the Corporate & Investment Bank, Consumer & Community Banking (“CCB”), Commercial Banking, Asset Management and certain corporate functions including Treasury and Chief Investment Office (“CIO”).
The valuation control function verifies fair value estimates provided by the risk-taking functions by leveraging independently derived prices, valuation inputs and other market data, where available. Where independent prices or inputs are not available, additional review is performed by the valuation control function to ensure the reasonableness of the estimates. The review may include evaluating the limited market activity including client unwinds, benchmarking of valuation inputs to those for similar instruments, decomposing the valuation of structured instruments into individual components, comparing expected to actual cash flows, reviewing profit and loss trends, and reviewing trends in collateral valuation. There are also additional levels of management review for more significant or complex positions.
The valuation control function determines any valuation adjustments that may be required to the estimates provided by the risk-taking functions. No adjustments are applied to the quoted market price for instruments classified within level 1 of the fair value hierarchy (see below for further information on the fair value hierarchy). For other positions, judgment is required to assess the need for valuation adjustments to appropriately reflect liquidity considerations, unobservable parameters, and, for certain portfolios that meet specified criteria, the size of the net open risk position. The determination of such adjustments follows a consistent framework across the Firm:
Liquidity valuation adjustments are considered where an observable external price or valuation parameter exists but is of lower reliability, potentially due to lower market activity. Liquidity valuation adjustments are applied and determined based on current market conditions. Factors that may be considered in determining the liquidity adjustment include analysis of: (1) the estimated bid-offer spread for the instrument being traded; (2) alternative pricing points for similar instruments in active markets; and (3) the range of reasonable values that the price or parameter could take.
The Firm manages certain portfolios of financial instruments on the basis of net open risk exposure and, as permitted by U.S. GAAP, has elected to estimate the fair value of such portfolios on the basis of a transfer of the entire net open risk position in an orderly transaction. Where this is the case, valuation adjustments may be necessary to reflect the cost of exiting a larger-than-normal market-size net open risk position. Where applied, such adjustments are based on factors that a relevant market participant would consider in the transfer of the net open risk position, including the size of the adverse market move that is likely to occur during the period required to reduce the net open risk position to a normal market-size.
Unobservable parameter valuation adjustments may be made when positions are valued using prices or input parameters to valuation models that are unobservable due to a lack of market activity or because they cannot be implied from observable market data. Such prices or parameters must be estimated and are, therefore, subject to management judgment. Unobservable parameter valuation adjustments are applied to reflect the uncertainty inherent in the resulting valuation estimate.
Where appropriate, the Firm also applies adjustments to its estimates of fair value in order to appropriately reflect counterparty credit quality, the Firm’s own creditworthiness and the impact of funding, utilizing a consistent framework across the Firm. For more information on such adjustments see Credit and funding adjustments on page 200 of this Note.
Valuation model review and approval
If prices or quotes are not available for an instrument or a similar instrument, fair value is generally determined using valuation models that consider relevant transaction data such as maturity and use as inputs market-based or independently sourced parameters. Where this is the case the price verification process described above is applied to the inputs to those models.
The Model Risk function is independent of the model owners. It reviews and approves a wide range of models, including risk management, valuation and regulatory capital models used by the Firm. The Model Risk review and governance functions are part of the Firm’s Model Risk unit, and the Firmwide Model Risk Executive reports to the Firm’s Chief Risk Officer (“CRO”). When reviewing a model, the Model Risk function analyzes and challenges the model methodology, and the reasonableness of model assumptions and may perform or require additional testing, including back-testing of model outcomes.
New valuation models, as well as material changes to existing valuation models, are reviewed and approved prior to implementation except where specified conditions are met, including the approval of an exception granted by the head of the Model Risk function. The Model Risk function performs an annual status assessment that considers developments in the product or market to determine whether valuation models which have already been reviewed need to be, on a full or partial basis, reviewed and approved again.
Valuation hierarchy
A three-level valuation hierarchy has been established under U.S. GAAP for disclosure of fair value measurements. The valuation hierarchy is based on the transparency of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows.
Level 1 – inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 – inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
Level 3 – one or more inputs to the valuation methodology are unobservable and significant to the fair value measurement.
A financial instrument’s categorization within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement.
The following table describes the valuation methodologies generally used by the Firm to measure its significant products/instruments at fair value, including the general classification of such instruments pursuant to the valuation hierarchy.
 
Product/instrument
 Valuation methodology
Classifications in the valuation hierarchy
 
Securities financing agreements
Valuations are based on discounted cash flows, which consider:
Level 2
 
• Derivative features: for further information refer to the discussion of derivatives below.
 
• Market rates for the respective maturity
 
• Collateral
 
Loans and lending-related commitments — wholesale
 
 
Trading portfolio
Where observable market data is available, valuations are based on:
Level 2 or 3
 
 
• Observed market prices (circumstances are infrequent)
 
 
 
• Relevant broker quotes
 
 
 
• Observed market prices for similar instruments
 
 
 
Where observable market data is unavailable or limited, valuations are based on discounted cash flows, which consider the following:
 
 
 
• Credit spreads derived from the cost of credit default swaps (“CDS”); or benchmark credit curves developed by the Firm, by industry and credit rating
 
 
 
• Prepayment speed
 
 
Loans held for investment and associated lending-related commitments
Valuations are based on discounted cash flows, which consider:
Predominantly level 3
 
• Credit spreads, derived from the cost of CDS; or benchmark credit curves developed by the Firm, by industry and credit rating
 
 
 
 
• Prepayment speed
 
 
 
Lending-related commitments are valued similar to loans and reflect the portion of an unused commitment expected, based on the Firm’s average portfolio historical experience, to become funded prior to an obligor default
 
 
 
 
 
 
 
 
 
For information regarding the valuation of loans measured at collateral value, see Note 14.
 
 
 
 
 
Loans — consumer
 
 
 
Held for investment consumer loans, excluding credit card
Valuations are based on discounted cash flows, which consider:
Predominantly level 3
 
• Expected lifetime credit losses -considering expected and current default rates, and loss severity
 
 
 
 
  Prepayment speed
 
 
 
  Discount rates
 
 
 
  Servicing costs
 
 
 
For information regarding the valuation of loans measured at collateral value, see Note 14.
 
 
 
 
 
Held for investment credit card receivables
Valuations are based on discounted cash flows, which consider:
Level 3
 
• Credit costs — allowance for loan losses is considered a reasonable proxy for the credit cost
 
 
 
 
• Projected interest income, late-fee revenue and loan repayment rates
 
 
• Discount rates
 
 
 
• Servicing costs
 
 
Trading loans — conforming residential mortgage loans expected to be sold
Fair value is based upon observable prices for mortgage-backed securities with similar collateral and incorporates adjustments to these prices to account for differences between the securities and the value of the underlying loans, which include credit characteristics, portfolio composition, and liquidity.
Predominantly level 2
 
 
 
 
 
 
Product/instrument
Valuation methodology, inputs and assumptions
Classifications in the valuation hierarchy
Investment and trading securities
Quoted market prices are used where available.
Level 1
 
In the absence of quoted market prices, securities are valued based on:
Level 2 or 3
 
• Observable market prices for similar securities
 
 
  Relevant broker quotes
 
 
  Discounted cash flows
 
 
In addition, the following inputs to discounted cash flows are used for the following products:
 
 
Mortgage- and asset-backed securities specific inputs:
 
 
  Collateral characteristics
 
 
• Deal-specific payment and loss allocations
 
 
• Current market assumptions related to yield, prepayment speed, conditional default rates and loss severity
 
 
Collateralized loan obligations (“CLOs”), specific inputs:
 
 
  Collateral characteristics
 
 
  Deal-specific payment and loss allocations
 
 
  Expected prepayment speed, conditional default rates, loss severity
 
 
  Credit spreads
 
 
• Credit rating data
 
Physical commodities
Valued using observable market prices or data
Predominantly Level 1 and 2
Derivatives
Exchange-traded derivatives that are actively traded and valued using the exchange price.
Level 1
 
Derivatives that are valued using models such as the Black-Scholes option pricing model, simulation models, or a combination of models, that use observable or unobservable valuation inputs (e.g., plain vanilla options and interest rate and credit default swaps). Inputs include:
Level 2 or 3
 
 
 
 
  Contractual terms including the period to maturity
 
 
  Readily observable parameters including interest rates and volatility
 
 
  Credit quality of the counterparty and of the Firm
 
 
  Market funding levels
 
 
  Correlation levels
 
 
In addition, the following specific inputs are used for the following derivatives that are valued based on models with significant unobservable inputs:
 
 
Structured credit derivatives specific inputs include:
 
 
  CDS spreads and recovery rates
 
 
  Credit correlation between the underlying debt instruments (levels are modeled on a transaction basis and calibrated to liquid benchmark tranche indices)
 
 
 
 
 
 
  Actual transactions, where available, are used to regularly recalibrate unobservable parameters
 
 
 
 
Certain long-dated equity option specific inputs include:
 
 
  Long-dated equity volatilities
 
 
Certain interest rate and foreign exchange (“FX) exotic options specific inputs include:
 
 
  Interest rate correlation
 
 
  Interest rate spread volatility
 
 
  Foreign exchange correlation
 
 
  Correlation between interest rates and foreign exchange rates
 
 
  Parameters describing the evolution of underlying interest rates
 
 
Certain commodity derivatives specific inputs include:
 
 
  Commodity volatility
 
 
• Forward commodity price
 
 
Additionally, adjustments are made to reflect counterparty credit quality (credit valuation adjustments or “CVA”), the Firm’s own creditworthiness (debit valuation adjustments or “DVA”), and funding valuation adjustment (“FVA”) to incorporate the impact of funding. See page 200 of this Note.
 
 
 
 
 
 
 
 
Product/instrument
Valuation methodology, inputs and assumptions
Classification in the valuation hierarchy
 
Mortgage servicing rights (“MSRs”)
See Mortgage servicing rights in Note 17.
Level 3
 
 
 
Private equity direct investments
Private equity direct investments
Level 2 or 3
 
 
Fair value is estimated using all available information and considering the range of potential inputs, including:



 
 
• Transaction prices
 
 
 
• Trading multiples of comparable public companies
 
 
 
• Operating performance of the underlying portfolio company
 
 
 
• Additional available inputs relevant to the investment
 
 
 
• Adjustments as required, since comparable public companies are not identical to the company being valued, and for company-specific issues and lack of liquidity
 
 
 
Public investments held in the Private Equity portfolio
Level 1 or 2
 
 
• Valued using observable market prices less adjustments for relevant restrictions, where applicable
 
 
 
 
 
Fund investments (i.e., mutual/collective investment funds, private equity funds, hedge funds, and real estate funds)
Net asset value (“NAV”)
 
 
• NAV is validated by sufficient level of observable activity (i.e., purchases and sales)
Level 1
 
 
 
• Adjustments to the NAV as required, for restrictions on redemption (e.g., lock up periods or withdrawal limitations) or where observable activity is limited
Level 2 or 3(a)
 
 
 
 
Beneficial interests issued by consolidated VIEs
Valued using observable market information, where available
Level 2 or 3
 
In the absence of observable market information, valuations are based on the fair value of the underlying assets held by the VIE
 
 
Long-term debt, not carried at fair value
Valuations are based on discounted cash flows, which consider:
Predominantly level 2
 
  Market rates for respective maturity
 
 
• The Firm’s own creditworthiness (DVA). See page 200 of
    this Note.
 
Structured notes (included in deposits, other borrowed funds and long-term debt)
• Valuations are based on discounted cash flow analyses that consider the embedded derivative and the terms and payment structure of the note.
• The embedded derivative features are considered using models such as the Black-Scholes option pricing model, simulation models, or a combination of models that use observable or unobservable valuation inputs, depending on the embedded derivative. The specific inputs used vary according to the nature of the embedded derivative features, as described in the discussion above regarding derivative valuation. Adjustments are then made to this base valuation to reflect the Firm’s own creditworthiness (DVA) and to incorporate the impact of funding (FVA). See page 200 of this Note.
Level 2 or 3
 
 
 
 

(a)
Excludes certain investments that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient.

The following table presents the asset and liabilities reported at fair value as of December 31, 2015 and 2014, by major product category and fair value hierarchy.
Assets and liabilities measured at fair value on a recurring basis

 
 
 
 
 
 
Fair value hierarchy
 
 
 
December 31, 2015 (in millions)
Level 1
Level 2
 
Level 3
 
Derivative netting adjustments
Total fair value
Federal funds sold and securities purchased under resale agreements
$

$
23,141

 
$

 
$

$
23,141

Securities borrowed

395

 

 

395

Trading assets:
 
 
 
 
 
 
 
Debt instruments:
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
U.S. government agencies(a)
6

31,815

 
715

 

32,536

Residential – nonagency

1,299

 
194

 

1,493

Commercial – nonagency

1,080

 
115

 

1,195

Total mortgage-backed securities
6

34,194

 
1,024

 

35,224

U.S. Treasury and government agencies(a)
12,036

6,985

 

 

19,021

Obligations of U.S. states and municipalities

6,986

 
651

 

7,637

Certificates of deposit, bankers’ acceptances and commercial paper

1,042

 

 

1,042

Non-U.S. government debt securities
27,974

25,064

 
74

 

53,112

Corporate debt securities

22,807

 
736

 

23,543

Loans(b)

22,211

 
6,604

 

28,815

Asset-backed securities

2,392

 
1,832

 

4,224

Total debt instruments
40,016

121,681

 
10,921

 

172,618

Equity securities
94,059

606

 
265

 

94,930

Physical commodities(c)
3,593

1,064

 

 

4,657

Other

11,152

 
744

 

11,896

Total debt and equity instruments(d)
137,668

134,503

 
11,930

 

284,101

Derivative receivables:
 
 
 
 
 
 
 
Interest rate
354

666,491

 
2,766

 
(643,248
)
26,363

Credit

48,850

 
2,618

 
(50,045
)
1,423

Foreign exchange
734

177,525

 
1,616

 
(162,698
)
17,177

Equity

35,150

 
709

 
(30,330
)
5,529

Commodity
108

24,720

 
237

 
(15,880
)
9,185

Total derivative receivables(e)
1,196

952,736

 
7,946

 
(902,201
)
59,677

Total trading assets
138,864

1,087,239

 
19,876

 
(902,201
)
343,778

Available-for-sale securities:
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
U.S. government agencies(a)

55,066

 

 

55,066

Residential – nonagency

27,618

 
1

 

27,619

Commercial – nonagency

22,897

 

 

22,897

Total mortgage-backed securities

105,581

 
1

 

105,582

U.S. Treasury and government agencies(a)
10,998

38

 

 

11,036

Obligations of U.S. states and municipalities

33,550

 

 

33,550

Certificates of deposit

283

 

 

283

Non-U.S. government debt securities
23,199

13,477

 

 

36,676

Corporate debt securities

12,436

 

 

12,436

Asset-backed securities:
 
 
 
 
 
 
 
Collateralized loan obligations

30,248

 
759

 

31,007

Other

9,033

 
64

 

9,097

Equity securities
2,087


 

 

2,087

Total available-for-sale securities
36,284

204,646

 
824

 

241,754

Loans

1,343

 
1,518

 

2,861

Mortgage servicing rights


 
6,608

 

6,608

Other assets:
 
 
 
 
 
 
 
Private equity investments(f)
102

101

 
1,657

 

1,860

All other
3,815

28

 
744

 

4,587

Total other assets
3,917

129

 
2,401

 

6,447

Total assets measured at fair value on a recurring basis
$
179,065

$
1,316,893

(g) 
$
31,227

(g) 
$
(902,201
)
$
624,984

Deposits
$

$
9,566

 
$
2,950

 
$

$
12,516

Federal funds purchased and securities loaned or sold under repurchase agreements

3,526

 

 

3,526

Other borrowed funds

9,272

 
639

 

9,911

Trading liabilities:
 
 
 
 
 
 


Debt and equity instruments(d)
53,845

20,199

 
63

 

74,107

Derivative payables:
 
 
 
 
 
 


Interest rate
216

633,060

 
1,890

 
(624,945
)
10,221

Credit

48,460

 
2,069

 
(48,988
)
1,541

Foreign exchange
669

187,890

 
2,341

 
(171,131
)
19,769

Equity

36,440

 
2,223

 
(29,480
)
9,183

Commodity
52

26,430

 
1,172

 
(15,578
)
12,076

Total derivative payables(e)
937

932,280

 
9,695

 
(890,122
)
52,790

Total trading liabilities
54,782

952,479

 
9,758

 
(890,122
)
126,897

Accounts payable and other liabilities
4,382


 
19

 

4,401

Beneficial interests issued by consolidated VIEs

238

 
549

 

787

Long-term debt

21,452

 
11,613

 

33,065

Total liabilities measured at fair value on a recurring basis
$
59,164

$
996,533

 
$
25,528

 
$
(890,122
)
$
191,103

 
Fair value hierarchy
 
 
 
 
December 31, 2014 (in millions)
Level 1
Level 2
 
Level 3
 
Derivative netting adjustments
 
Total fair value
Federal funds sold and securities purchased under resale agreements
$

$
28,585

 
$

 
$

 
$
28,585

Securities borrowed

992

 

 

 
992

Trading assets:
 
 
 
 
 
 
 
 
Debt instruments:
 
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
 
U.S. government agencies(a)
14

31,904

 
922

 

 
32,840

Residential – nonagency

1,381

 
663

 

 
2,044

Commercial – nonagency

927

 
306

 

 
1,233

Total mortgage-backed securities
14

34,212

 
1,891

 

 
36,117

U.S. Treasury and government agencies(a)
17,816

8,460

 

 

 
26,276

Obligations of U.S. states and municipalities

9,298

 
1,273

 

 
10,571

Certificates of deposit, bankers’ acceptances and commercial paper

1,429

 

 

 
1,429

Non-U.S. government debt securities
25,854

27,294

 
302

 

 
53,450

Corporate debt securities

28,099

 
2,989

 

 
31,088

Loans(b)

23,080

 
13,287

 

 
36,367

Asset-backed securities

3,088

 
1,264

 

 
4,352

Total debt instruments
43,684

134,960

 
21,006

 

 
199,650

Equity securities
104,890

624

 
431

 

 
105,945

Physical commodities(c)
2,739

1,741

 
2

 

 
4,482

Other

8,762

 
1,050

 

 
9,812

Total debt and equity instruments(d)
151,313

146,087

 
22,489

 

 
319,889

Derivative receivables:
 
 
 
 
 
 
 
 
Interest rate
473

945,635

(g) 
4,149

 
(916,532
)
(g) 
33,725

Credit

73,853

 
2,989

 
(75,004
)
 
1,838

Foreign exchange
758

212,153

(g) 
2,276

 
(193,934
)
(g) 
21,253

Equity

39,937

(g) 
2,552

 
(34,312
)
(g) 
8,177

Commodity
247

42,807

 
599

 
(29,671
)
 
13,982

Total derivative receivables(e)
1,478

1,314,385

(g) 
12,565

 
(1,249,453
)
(g) 
78,975

Total trading assets
152,791

1,460,472

(g) 
35,054

 
(1,249,453
)
(g) 
398,864

Available-for-sale securities:
 
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
 
U.S. government agencies(a)

65,319

 

 

 
65,319

Residential – nonagency

50,865

 
30

 

 
50,895

Commercial – nonagency

21,009

 
99

 

 
21,108

Total mortgage-backed securities

137,193

 
129

 

 
137,322

U.S. Treasury and government agencies(a)
13,591

54

 

 

 
13,645

Obligations of U.S. states and municipalities

30,068

 

 

 
30,068

Certificates of deposit

1,103

 

 

 
1,103

Non-U.S. government debt securities
24,074

28,669

 

 

 
52,743

Corporate debt securities

18,532

 

 

 
18,532

Asset-backed securities:
 
 
 
 
 
 
 
 
Collateralized loan obligations

29,402

 
792

 

 
30,194

Other

12,499

 
116

 

 
12,615

Equity securities
2,530


 

 

 
2,530

Total available-for-sale securities
40,195

257,520

 
1,037

 

 
298,752

Loans

70

 
2,541

 

 
2,611

Mortgage servicing rights


 
7,436

 

 
7,436

Other assets:
 
 
 
 
 
 
 
 
Private equity investments(f)
648

2,624

 
2,225

 

 
5,497

All other
4,018

17

 
959

 

 
4,994

Total other assets
4,666

2,641

 
3,184

 

 
10,491

Total assets measured at fair value on a recurring basis
$
197,652

$
1,750,280

(g) 
$
49,252

 
$
(1,249,453
)
(g) 
$
747,731

Deposits
$

$
5,948

 
$
2,859

 
$

 
$
8,807

Federal funds purchased and securities loaned or sold under repurchase agreements

2,979

 

 

 
2,979

Other borrowed funds

13,286

 
1,453

 

 
14,739

Trading liabilities:
 
 
 
 
 
 
 
 
Debt and equity instruments(d)
62,914

18,713

 
72

 

 
81,699

Derivative payables:
 
 
 
 
 
 
 
 
Interest rate
499

914,357

(g) 
3,523

 
(900,634
)
(g) 
17,745

Credit

73,095

 
2,800

 
(74,302
)
 
1,593

Foreign exchange
746

221,066

(g) 
2,802

 
(201,644
)
(g) 
22,970

Equity

41,925

(g) 
4,337

 
(34,522
)
(g) 
11,740

Commodity
141

44,318

 
1,164

 
(28,555
)
 
17,068

Total derivative payables(e)
1,386

1,294,761

(g) 
14,626

 
(1,239,657
)
(g) 
71,116

Total trading liabilities
64,300

1,313,474

(g) 
14,698

 
(1,239,657
)
(g) 
152,815

Accounts payable and other liabilities (g)
4,129


 
26

 

 
4,155

Beneficial interests issued by consolidated VIEs

1,016

 
1,146

 

 
2,162

Long-term debt

18,349

 
11,877

 

 
30,226

Total liabilities measured at fair value on a recurring basis
$
68,429

$
1,355,052

(g) 
$
32,059

 
$
(1,239,657
)
(g) 
$
215,883

Note: Effective April 1, 2015, the Firm adopted new accounting guidance for investments in certain entities that calculate net asset value per share (or its equivalent). As a result of the adoption of this new guidance, certain investments that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient are not required to be classified in the fair value hierarchy. At December 31, 2015 and 2014, the fair values of these investments, which include certain hedge funds, private equity funds, real estate and other funds, were $1.2 billion and $1.5 billion, respectively, of which $337 million and $1.2 billion had been previously classified in level 2 and level 3, respectively, at December 31, 2014. Included on the Firm’s balance sheet at December 31, 2015 and 2014, were trading assets of $61 million and $124 million, respectively, and other assets of $1.2 billion and $1.4 billion, respectively. The guidance was required to be applied retrospectively, and accordingly, prior period amounts have been revised to conform with the current period presentation.
(a)
At December 31, 2015 and 2014, included total U.S. government-sponsored enterprise obligations of $67.0 billion and $84.1 billion, respectively, which were predominantly mortgage-related.
(b)
At December 31, 2015 and 2014, included within trading loans were $11.8 billion and $17.0 billion, respectively, of residential first-lien mortgages, and $4.3 billion and $5.8 billion, respectively, of commercial first-lien mortgages. Residential mortgage loans include conforming mortgage loans originated with the intent to sell to U.S. government agencies of $5.3 billion and $7.7 billion, respectively, and reverse mortgages of $2.5 billion and $3.4 billion, respectively.
(c)
Physical commodities inventories are generally accounted for at the lower of cost or market. “Market” is a term defined in U.S. GAAP as not exceeding fair value less costs to sell (“transaction costs”). Transaction costs for the Firm’s physical commodities inventories are either not applicable or immaterial to the value of the inventory. Therefore, market approximates fair value for the Firm’s physical commodities inventories. When fair value hedging has been applied (or when market is below cost), the carrying value of physical commodities approximates fair value, because under fair value hedge accounting, the cost basis is adjusted for changes in fair value. For a further discussion of the Firm’s hedge accounting relationships, see Note 6. To provide consistent fair value disclosure information, all physical commodities inventories have been included in each period presented.
(d)
Balances reflect the reduction of securities owned (long positions) by the amount of identical securities sold but not yet purchased (short positions).
(e)
As permitted under U.S. GAAP, the Firm has elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. For purposes of the tables above, the Firm does not reduce derivative receivables and derivative payables balances for this netting adjustment, either within or across the levels of the fair value hierarchy, as such netting is not relevant to a presentation based on the transparency of inputs to the valuation of an asset or liability. However, if the Firm were to net such balances within level 3, the reduction in the level 3 derivative receivables and payables balances would be $546 million and $2.5 billion at December 31, 2015 and 2014, respectively; this is exclusive of the netting benefit associated with cash collateral, which would further reduce the level 3 balances.
(f)
Private equity instruments represent investments within the Corporate line of business. The cost basis of the private equity investment portfolio totaled $3.5 billion and $6.0 billion at December 31, 2015 and 2014, respectively.
(g)
Certain prior period amounts (including the corresponding fair value parenthetical disclosure for accounts payable and other liabilities on the Consolidated balance sheets) were revised to conform with the current period presentation.

Transfers between levels for instruments carried at fair value on a recurring basis
For the years ended December 31, 2015 and 2014, there were no significant transfers between levels 1 and 2.
During the year ended December 31, 2015, transfers from level 3 to level 2 and from level 2 to level 3 included the following:
$3.1 billion of long-term debt and $1.0 billion of deposits driven by an increase in observability on certain structured notes with embedded interest rate and FX derivatives and a reduction of the significance in the unobservable inputs for certain structured notes with embedded equity derivatives
$2.1 billion of gross equity derivatives for both receivables and payables as a result of an increase in observability and a decrease in the significance in unobservable inputs; partially offset by transfers into level 3 resulting in net transfers of approximately $1.2 billion for both receivables and payables
$2.8 billion of trading loans driven by an increase in observability of certain collateralized financing transactions; and $2.4 billion of corporate debt driven by a decrease in the significance in the unobservable inputs and an increase in observability for certain structured products
During the year ended December 31, 2014, transfers from level 3 to level 2 included the following:
$4.3 billion and $4.4 billion of gross equity derivative receivables and payables, respectively, due to increased observability of certain equity option valuation inputs
$2.7 billion of trading loans, $2.6 billion of margin loans, $2.3 billion of private equity investments, $2.0 billion of corporate debt, and $1.3 billion of long-term debt, based on increased liquidity and price transparency
Transfers from level 2 into level 3 included $1.1 billion of other borrowed funds, $1.1 billion of trading loans and $1.0 billion of long-term debt, based on a decrease in observability of valuation inputs and price transparency.
During the year ended December 31, 2013, transfers from level 3 to level 2 included the following:
Certain highly rated CLOs, including $27.4 billion held in the Firms available-for-sale (“AFS”) securities portfolio and $1.4 billion held in the trading portfolio, based on increased liquidity and price transparency;
$1.3 billion of long-term debt, largely driven by an increase in observability of certain equity structured notes.
Transfers from level 2 to level 3 included $1.4 billion of corporate debt securities in the trading portfolio largely driven by a decrease in observability for certain credit instruments.
All transfers are assumed to occur at the beginning of the quarterly reporting period in which they occur.
Level 3 valuations
The Firm has established well-documented processes for determining fair value, including for instruments where fair value is estimated using significant unobservable inputs (level 3). For further information on the Firm’s valuation process and a detailed discussion of the determination of fair value for individual financial instruments, see pages 185–188 of this Note.
Estimating fair value requires the application of judgment. The type and level of judgment required is largely dependent on the amount of observable market information available to the Firm. For instruments valued using internally developed models that use significant unobservable inputs and are therefore classified within level 3 of the fair value hierarchy, judgments used to estimate fair value are more significant than those required when estimating the fair value of instruments classified within levels 1 and 2.
In arriving at an estimate of fair value for an instrument within level 3, management must first determine the appropriate model to use. Second, due to the lack of observability of significant inputs, management must assess all relevant empirical data in deriving valuation inputs including, but not limited to, transaction details, yield curves, interest rates, prepayment speed, default rates, volatilities, correlations, equity or debt prices, valuations of comparable instruments, foreign exchange rates and credit curves.
The following table presents the Firm’s primary level 3 financial instruments, the valuation techniques used to measure the fair value of those financial instruments, the significant unobservable inputs, the range of values for those inputs and, for certain instruments, the weighted averages of such inputs. While the determination to classify an instrument within level 3 is based on the significance of the unobservable inputs to the overall fair value measurement, level 3 financial instruments typically include observable components (that is, components that are actively quoted and can be validated to external sources) in addition to the unobservable components. The level 1 and/or level 2 inputs are not included in the table. In addition, the Firm manages the risk of the observable components of level 3 financial instruments using securities and derivative positions that are classified within levels 1 or 2 of the fair value hierarchy.
The range of values presented in the table is representative of the highest and lowest level input used to value the significant groups of instruments within a product/instrument classification. Where provided, the weighted averages of the input values presented in the table are calculated based on the fair value of the instruments that the input is being used to value.
In the Firm’s view, the input range and the weighted average value do not reflect the degree of input uncertainty or an assessment of the reasonableness of the Firm’s estimates and assumptions. Rather, they reflect the characteristics of the various instruments held by the Firm and the relative distribution of instruments within the range of characteristics. For example, two option contracts may have similar levels of market risk exposure and valuation uncertainty, but may have significantly different implied volatility levels because the option contracts have different underlyings, tenors, or strike prices. The input range and weighted average values will therefore vary from period-to-period and parameter-to-parameter based on the characteristics of the instruments held by the Firm at each balance sheet date.
For the Firm’s derivatives and structured notes positions classified within level 3 at December 31, 2015, interest rate correlation inputs used in estimating fair value were concentrated towards the upper end of the range presented; equities correlation inputs were concentrated at the lower end of the range; the credit correlation inputs were distributed across the range presented; and the foreign exchange correlation inputs were concentrated at the top end of the range presented. In addition, the interest rate volatility inputs and the foreign exchange correlation inputs used in estimating fair value were each concentrated at the upper end of the range presented. The equity volatilities are concentrated in the lower half end of the range. The forward commodity prices used in estimating the fair value of commodity derivatives were concentrated within the lower end of the range presented.
Level 3 inputs(a)
 
December 31, 2015 (in millions, except for ratios and basis points)
 
 
 
 
 
Product/Instrument
Fair value
 
Principal valuation technique
Unobservable inputs
Range of input values
Weighted average
Residential mortgage-backed securities and loans
$
5,212

 
Discounted cash flows
Yield
3%

-
26%
6%
 
 
 
Prepayment speed
0%

-
20%
6%
 
 
 
 
Conditional default rate
0%

-
33%
2%
 
 
 
 
Loss severity
0%

-
100%
28%
Commercial mortgage-backed securities and loans(b)
2,844

 
Discounted cash flows
Yield
1%

-
25%
6%
 
 
 
Conditional default rate
0%

-
91%
29%
 
 
 
 
Loss severity
40%
40%
Corporate debt securities, obligations of U.S. states and municipalities, and other(c)
3,277

 
Discounted cash flows
Credit spread
60 bps

-
225 bps
146 bps
 
 
 
Yield
1%

-
20%
5%
2,740

 
Market comparables
Price
$

-
$168
$89
Net interest rate derivatives
876

 
Option pricing
Interest rate correlation
(52
)%
-
99%
 
 
 
 
 
Interest rate spread volatility
3%

-
38%
 
Net credit derivatives(b)(c)
549

 
Discounted cash flows
Credit correlation
35%

-
90%
 
Net foreign exchange derivatives
(725
)
 
Option pricing
Foreign exchange correlation
0%

-
60%
 
Net equity derivatives
(1,514
)
 
Option pricing
Equity volatility
20%

-
65%
 
Net commodity derivatives
(935
)
 
Discounted cash flows
Forward commodity price
$
22

-
$46 per barrel
Collateralized loan obligations
759

 
Discounted cash flows
Credit spread
354 bps

-
550 bps
396 bps
 
 
 
 
Prepayment speed
20%
20%
 
 
 
 
Conditional default rate
2%
2%
 
 
 
 
Loss severity
40%
40%
 
180

 
Market comparables
Price
$

-
$99
$69
Mortgage servicing rights
6,608

 
Discounted cash flows
Refer to Note 17
 
Private equity investments
1,657

 
Market comparables
EBITDA multiple
7.2x

-
10.4x
8.5x
 
 
 
Liquidity adjustment
0%

-
13%
8%
Long-term debt, other borrowed funds, and deposits(d)
14,707

 
Option pricing
Interest rate correlation
(52
)%
-
99%
 
 
 
 
Interest rate spread volatility
3%

-
38%
 
 
 
 
Foreign exchange correlation
0%

-
60%
 
 
 
 
Equity correlation
(50
)%
-
80%
 
 
495

 
Discounted cash flows
Credit correlation
35%

-
90%
 
Beneficial interests issued by consolidated VIEs(e)
549

 
Discounted cash flows
Yield
4%

-
28%
4%
 
 
 
 
Prepayment Speed
1%

-
12%
6%
 
 
 
 
Conditional default rate
2%

-
15%
2%
 
 
 
 
Loss severity
30%

-
100%
31%
(a)
The categories presented in the table have been aggregated based upon the product type, which may differ from their classification on the Consolidated balance sheets.
(b)
The unobservable inputs and associated input ranges for approximately $349 million of credit derivative receivables and $310 million of credit derivative payables with underlying commercial mortgage risk have been included in the inputs and ranges provided for commercial mortgage-backed securities and loans.
(c)
The unobservable inputs and associated input ranges for approximately $434 million of credit derivative receivables and $401 million of credit derivative payables with underlying asset-backed securities risk have been included in the inputs and ranges provided for corporate debt securities, obligations of U.S. states and municipalities and other.
(d)
Long-term debt, other borrowed funds and deposits include structured notes issued by the Firm that are predominantly financial instruments containing embedded derivatives. The estimation of the fair value of structured notes is predominantly based on the derivative features embedded within the instruments. The significant unobservable inputs are broadly consistent with those presented for derivative receivables.
(e) The parameters are related to residential mortgage-backed securities.


Changes in and ranges of unobservable inputs
The following discussion provides a description of the impact on a fair value measurement of a change in each unobservable input in isolation, and the interrelationship between unobservable inputs, where relevant and significant. The impact of changes in inputs may not be independent as a change in one unobservable input may give rise to a change in another unobservable input; where relationships exist between two unobservable inputs, those relationships are discussed below. Relationships may also exist between observable and unobservable inputs (for example, as observable interest rates rise, unobservable prepayment rates decline); such relationships have not been included in the discussion below. In addition, for each of the individual relationships described below, the inverse relationship would also generally apply.
In addition, the following discussion provides a description of attributes of the underlying instruments and external market factors that affect the range of inputs used in the valuation of the Firm’s positions.
Yield – The yield of an asset is the interest rate used to discount future cash flows in a discounted cash flow calculation. An increase in the yield, in isolation, would result in a decrease in a fair value measurement.
Credit spread – The credit spread is the amount of additional annualized return over the market interest rate that a market participant would demand for taking exposure to the credit risk of an instrument. The credit spread for an instrument forms part of the discount rate used in a discounted cash flow calculation. Generally, an increase in the credit spread would result in a decrease in a fair value measurement.
The yield and the credit spread of a particular mortgage-backed security primarily reflect the risk inherent in the instrument. The yield is also impacted by the absolute level of the coupon paid by the instrument (which may not correspond directly to the level of inherent risk). Therefore, the range of yield and credit spreads reflects the range of risk inherent in various instruments owned by the Firm. The risk inherent in mortgage-backed securities is driven by the subordination of the security being valued and the characteristics of the underlying mortgages within the collateralized pool, including borrower FICO scores, loan-to-value ratios for residential mortgages and the nature of the property and/or any tenants for commercial mortgages. For corporate debt securities, obligations of U.S. states and municipalities and other similar instruments, credit spreads reflect the credit quality of the obligor and the tenor of the obligation.
Prepayment speed – The prepayment speed is a measure of the voluntary unscheduled principal repayments of a prepayable obligation in a collateralized pool. Prepayment speeds generally decline as borrower delinquencies rise. An increase in prepayment speeds, in isolation, would result in a decrease in a fair value measurement of assets valued at a premium to par and an increase in a fair value measurement of assets valued at a discount to par.
Prepayment speeds may vary from collateral pool to collateral pool, and are driven by the type and location of the underlying borrower, the remaining tenor of the obligation as well as the level and type (e.g., fixed or floating) of interest rate being paid by the borrower. Typically collateral pools with higher borrower credit quality have a higher prepayment rate than those with lower borrower credit quality, all other factors being equal.
Conditional default rate – The conditional default rate is a measure of the reduction in the outstanding collateral balance underlying a collateralized obligation as a result of defaults. While there is typically no direct relationship between conditional default rates and prepayment speeds, collateralized obligations for which the underlying collateral has high prepayment speeds will tend to have lower conditional default rates. An increase in conditional default rates would generally be accompanied by an increase in loss severity and an increase in credit spreads. An increase in the conditional default rate, in isolation, would result in a decrease in a fair value measurement. Conditional default rates reflect the quality of the collateral underlying a securitization and the structure of the securitization itself. Based on the types of securities owned in the Firm’s market-making portfolios, conditional default rates are most typically at the lower end of the range presented.
Loss severity – The loss severity (the inverse concept is the recovery rate) is the expected amount of future realized losses resulting from the ultimate liquidation of a particular loan, expressed as the net amount of loss relative to the outstanding loan balance. An increase in loss severity is generally accompanied by an increase in conditional default rates. An increase in the loss severity, in isolation, would result in a decrease in a fair value measurement.
The loss severity applied in valuing a mortgage-backed security investment depends on factors relating to the underlying mortgages, including the loan-to-value ratio, the nature of the lender’s lien on the property and other instrument-specific factors.
Correlation – Correlation is a measure of the relationship between the movements of two variables (e.g., how the change in one variable influences the change in the other). Correlation is a pricing input for a derivative product where the payoff is driven by one or more underlying risks. Correlation inputs are related to the type of derivative (e.g., interest rate, credit, equity and foreign exchange) due to the nature of the underlying risks. When parameters are positively correlated, an increase in one parameter will result in an increase in the other parameter. When parameters are negatively correlated, an increase in one parameter will result in a decrease in the other parameter. An increase in correlation can result in an increase or a decrease in a fair value measurement. Given a short correlation position, an increase in correlation, in isolation, would generally result in a decrease in a fair value measurement. The range of correlation inputs between risks within the same asset class are generally narrower than those between underlying risks across asset classes. In addition, the ranges of credit correlation inputs tend to be narrower than those affecting other asset classes.
The level of correlation used in the valuation of derivatives with multiple underlying risks depends on a number of factors including the nature of those risks. For example, the correlation between two credit risk exposures would be different than that between two interest rate risk exposures. Similarly, the tenor of the transaction may also impact the correlation input as the relationship between the underlying risks may be different over different time periods. Furthermore, correlation levels are very much dependent on market conditions and could have a relatively wide range of levels within or across asset classes over time, particularly in volatile market conditions.
Volatility – Volatility is a measure of the variability in possible returns for an instrument, parameter or market index given how much the particular instrument, parameter or index changes in value over time. Volatility is a pricing input for options, including equity options, commodity options, and interest rate options. Generally, the higher the volatility of the underlying, the riskier the instrument. Given a long position in an option, an increase in volatility, in isolation, would generally result in an increase in a fair value measurement.
The level of volatility used in the valuation of a particular option-based derivative depends on a number of factors, including the nature of the risk underlying the option (e.g., the volatility of a particular equity security may be significantly different from that of a particular commodity index), the tenor of the derivative as well as the strike price of the option.
EBITDA multiple – EBITDA multiples refer to the input (often derived from the value of a comparable company) that is multiplied by the historic and/or expected earnings before interest, taxes, depreciation and amortization (“EBITDA”) of a company in order to estimate the company’s value. An increase in the EBITDA multiple, in isolation, net of adjustments, would result in an increase in a fair value measurement.
Changes in level 3 recurring fair value measurements
The following tables include a rollforward of the Consolidated balance sheets amounts (including changes in fair value) for financial instruments classified by the Firm within level 3 of the fair value hierarchy for the years ended December 31, 2015, 2014 and 2013. When a determination is made to classify a financial instrument within level 3, the determination is based on the significance of the unobservable parameters to the overall fair value measurement. However, level 3 financial instruments typically include, in addition to the unobservable or level 3 components, observable components (that is, components that are actively quoted and can be validated to external sources); accordingly, the gains and losses in the table below include changes in fair value due in part to observable factors that are part of the valuation methodology. Also, the Firm risk-manages the observable components of level 3 financial instruments using securities and derivative positions that are classified within level 1 or 2 of the fair value hierarchy; as these level 1 and level 2 risk management instruments are not included below, the gains or losses in the following tables do not reflect the effect of the Firm’s risk management activities related to such level 3 instruments.
 
Fair value measurements using significant unobservable inputs
 
 
Year ended
December 31, 2015
(in millions)
Fair value at January 1, 2015
Total realized/unrealized gains/(losses)
 
 
 
 
Transfers into and/or out of level 3(i)
Fair value at Dec. 31, 2015
 
Change in unrealized gains/(losses) related to financial instruments held at Dec. 31, 2015
Purchases(g)
Sales
 
Settlements(h)
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Trading assets:
 
 
 
 
 
 
 
 
 
 
 
 
Debt instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
U.S. government agencies
$
922

$
(28
)
 
$
327

$
(303
)
 
$
(132
)
$
(71
)
$
715

 
$
(27
)
 
Residential – nonagency
663

130

 
253

(611
)
 
(23
)
(218
)
194

 
4

 
Commercial – nonagency
306

(14
)
 
246

(262
)
 
(22
)
(139
)
115

 
(5
)
 
Total mortgage-backed securities
1,891

88

 
826

(1,176
)
 
(177
)
(428
)
1,024

 
(28
)
 
Obligations of U.S. states and municipalities
1,273

14

 
352

(133
)
 
(27
)
(828
)
651

 
(1
)
 
Non-U.S. government debt securities
302

9

 
205

(123
)
 
(64
)
(255
)
74

 
(16
)
 
Corporate debt securities
2,989

(77
)
 
1,171

(1,038
)
 
(125
)
(2,184
)
736

 
2

 
Loans
13,287

(174
)
 
3,532

(4,661
)
 
(3,112
)
(2,268
)
6,604

 
(181
)
 
Asset-backed securities
1,264

(41
)
 
1,920

(1,229
)
 
(35
)
(47
)
1,832

 
(32
)
 
Total debt instruments
21,006

(181
)
 
8,006

(8,360
)
 
(3,540
)
(6,010
)
10,921

 
(256
)
 
Equity securities
431

96

 
89

(193
)
 
(26
)
(132
)
265

 
82

 
Physical commodities
2

(2
)
 


 



 

 
Other
1,050

119

 
1,581

(1,313
)
 
192

(885
)
744

 
85

 
Total trading assets – debt and equity instruments
22,489

32

(c) 
9,676

(9,866
)
 
(3,374
)
(7,027
)
11,930

 
(89
)
(c) 
Net derivative receivables:(a)
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate
626

962

 
513

(173
)
 
(732
)
(320
)
876

 
263

 
Credit
189

118

 
129

(136
)
 
165

84

549

 
260

 
Foreign exchange
(526
)
657

 
19

(149
)
 
(296
)
(430
)
(725
)
 
49

 
Equity
(1,785
)
731

 
890

(1,262
)
 
(158
)
70

(1,514
)
 
5

 
Commodity
(565
)
(856
)
 
1

(24
)
 
512

(3
)
(935
)
 
(41
)
 
Total net derivative receivables
(2,061
)
1,612

(c) 
1,552

(1,744
)
 
(509
)
(599
)
(1,749
)
 
536

(c) 
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
 
 
 
Asset-backed securities
908

(32
)
 
51

(43
)
 
(61
)

823

 
(28
)
 
Other
129


 


 
(29
)
(99
)
1

 

 
Total available-for-sale securities
1,037

(32
)
(d) 
51

(43
)
 
(90
)
(99
)
824

 
(28
)
(d) 
Loans
2,541

(133
)
(c) 
1,290

(92
)
 
(1,241
)
(847
)
1,518

 
(32
)
(c) 
Mortgage servicing rights
7,436

(405
)
(e) 
985

(486
)
 
(922
)

6,608

 
(405
)
(e) 
Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
Private equity investments
2,225

(120
)
(c) 
281

(362
)
 
(187
)
(180
)
1,657

 
(304
)
(c) 
All other
959

91

(f) 
65

(147
)
 
(224
)

744

 
15

(f) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value measurements using significant unobservable inputs
 
 
Year ended
December 31, 2015
(in millions)
Fair value at January 1, 2015
Total realized/unrealized (gains)/losses
 
 
 
 
Transfers into and/or out of level 3(i)
Fair value at Dec. 31, 2015
 
Change in unrealized (gains)/losses related to financial instruments held at Dec. 31, 2015
Purchases(g)
Sales
Issuances
Settlements(h)
Liabilities:(b)
 
 
 
 
 
 
 
 
 
 
 
 
Deposits
$
2,859

$
(39
)
(c) 
$

$

$
1,993

$
(850
)
$
(1,013
)
$
2,950

 
$
(29
)
(c) 
Other borrowed funds
1,453

(697
)
(c) 


3,334

(2,963
)
(488
)
639

 
(57
)
(c) 
Trading liabilities – debt and equity instruments
72

15

(c) 
(163
)
160


(17
)
(4
)
63

 
(4
)
(c) 
Accounts payable and other liabilities
26


 



(7
)

19

 

 
Beneficial interests issued by consolidated VIEs
1,146

(82
)
(c) 


286

(574
)
(227
)
549

 
(63
)
(c) 
Long-term debt
11,877

(480
)
(c) 
(58
)

9,359

(6,299
)
(2,786
)
11,613

 
385

(c) 
 
Fair value measurements using significant unobservable inputs
 
 
Year ended
December 31, 2014
(in millions)
Fair value at January 1, 2014
Total realized/unrealized gains/(losses)
 
 
 
 
 
 
Transfers into and/or out of level 3(i)
Fair value at
Dec. 31, 2014
Change in unrealized gains/(losses) related to financial instruments held at Dec. 31, 2014
Purchases(g)
 
Sales
 
 
Settlements(h)
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trading assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Debt instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. government agencies
$
1,005

$
(97
)
 
$
351

 
$
(186
)
 
 
$
(121
)
$
(30
)
$
922

 
$
(92
)
 
Residential – nonagency
726

66

 
827

 
(761
)
 
 
(41
)
(154
)
663

 
(15
)
 
Commercial – nonagency
432

17

 
980

 
(914
)
 
 
(60
)
(149
)
306

 
(12
)
 
Total mortgage-backed securities
2,163

(14
)
 
2,158

 
(1,861
)
 
 
(222
)
(333
)
1,891

 
(119
)
 
Obligations of U.S. states and municipalities
1,382

90

 
298

 
(358
)
 
 
(139
)

1,273

 
(27
)
 
Non-U.S. government debt securities
143

24

 
719

 
(617
)
 
 
(3
)
36

302

 
10

 
Corporate debt securities
5,920

210

 
5,854

 
(3,372
)
 
 
(4,531
)
(1,092
)
2,989

 
379

 
Loans
13,455

387

 
13,551

 
(7,917
)
 
 
(4,623
)
(1,566
)
13,287

 
123

 
Asset-backed securities
1,272

19

 
2,240

 
(2,126
)
 
 
(283
)
142

1,264

 
(30
)
 
Total debt instruments
24,335

716

 
24,820

 
(16,251
)
 
 
(9,801
)
(2,813
)
21,006

 
336

 
Equity securities
867

113

 
248

 
(259
)
 
 
(286
)
(252
)
431

 
46

 
Physical commodities
4

(1
)
 

 

 
 
(1
)

2

 

 
Other
2,000

239

 
1,426

 
(276
)
 
 
(201
)
(2,138
)
1,050

 
329

 
Total trading assets – debt and equity instruments
27,206

1,067

(c) 
26,494

 
(16,786
)
 
 
(10,289
)
(5,203
)
22,489

 
711

(c) 
Net derivative receivables:(a)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate
2,379

184

 
198

 
(256
)
 
 
(1,771
)
(108
)
626

 
(853
)
 
Credit
95

(149
)
 
272

 
(47
)
 
 
92

(74
)
189

 
(107
)
 
Foreign exchange
(1,200
)
(137
)
 
139

 
(27
)
 
 
668

31

(526
)
 
(62
)
 
Equity
(1,063
)
154

 
2,044

 
(2,863
)
 
 
10

(67
)
(1,785
)
 
583

 
Commodity
115

(465
)
 
1

 
(113
)
 
 
(109
)
6

(565
)
 
(186
)
 
Total net derivative receivables
326

(413
)
(c) 
2,654

 
(3,306
)
 
 
(1,110
)
(212
)
(2,061
)
 
(625
)
(c) 
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asset-backed securities
1,088

(41
)
 
275

 
(2
)
 
 
(101
)
(311
)
908

 
(40
)
 
Other
1,234

(19
)
 
122

 

 
 
(223
)
(985
)
129

 
(2
)
 
Total available-for-sale securities
2,322

(60
)
(d) 
397

 
(2
)
 
 
(324
)
(1,296
)
1,037

 
(42
)
(d) 
Loans
1,931

(254
)
(c) 
3,258

 
(845
)
 
 
(1,549
)

2,541

 
(234
)
(c) 
Mortgage servicing rights
9,614

(1,826
)
(e) 
768

 
(209
)
 
 
(911
)

7,436

 
(1,826
)
(e) 
Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Private equity investments
5,816

400

(c) 
145

 
(1,967
)
 
 
(197
)
(1,972
)
2,225

 
33

(c) 
All other
1,382

83

(f) 
10

 
(357
)
 
 
(159
)

959

 
59

(f) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value measurements using significant unobservable inputs
 
 
Year ended
December 31, 2014
(in millions)
Fair value at January 1, 2014
Total realized/unrealized (gains)/losses
 
 
 
 
 
 
Transfers into and/or out of level 3(i)
Fair value at Dec. 31, 2014
Change in unrealized (gains)/losses related to financial instruments held at Dec. 31, 2014
Purchases(g)
 
Sales
 
Issuances
Settlements(h)
Liabilities:(b)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Deposits
$
2,255

$
149

(c) 
$

 
$

 
$
1,578

$
(197
)
$
(926
)
$
2,859

 
$
130

(c) 
Other borrowed funds
2,074

(596
)
(c) 

 

 
5,377

(6,127
)
725

1,453

 
(415
)
(c) 
Trading liabilities – debt and equity instruments
113

(5
)
(c) 
(305
)
 
323

 

(5
)
(49
)
72

 
2

(c) 
Accounts payable and other liabilities

27

(c) 

 

 

(1
)

26

 

 
Beneficial interests issued by consolidated VIEs
1,240

(4
)
(c) 

 

 
775

(763
)
(102
)
1,146

 
(22
)
(c) 
Long-term debt
10,008

(40
)
(c) 

 

 
7,421

(5,231
)
(281
)
11,877

 
(9
)
(c) 

 
Fair value measurements using significant unobservable inputs
 
 
Year ended
December 31, 2013
(in millions)
Fair value at January 1, 2013
Total realized/unrealized gains/(losses)
 
 
 
 
 
 
Transfers into and/or out of level 3(i)
Fair value at
Dec. 31, 2013
Change in unrealized gains/(losses) related to financial instruments held at Dec. 31, 2013
Purchases(g)
 
Sales
 
 
Settlements(h)
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trading assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Debt instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. government agencies
$
498

$
169

 
$
819

 
$
(381
)
 
 
$
(100
)
$

$
1,005

 
$
200

 
Residential – nonagency
663

407

 
780

 
(1,028
)
 
 
(91
)
(5
)
726

 
205

 
Commercial – nonagency
1,207

114

 
841

 
(1,522
)
 
 
(208
)

432

 
(4
)
 
Total mortgage-backed securities
2,368

690

 
2,440

 
(2,931
)
 
 
(399
)
(5
)
2,163

 
401

 
Obligations of U.S. states and municipalities
1,436

71

 
472

 
(251
)
 
 
(346
)

1,382

 
18

 
Non-U.S. government debt securities
67

4

 
1,449

 
(1,479
)
 
 
(8
)
110

143

 
(1
)
 
Corporate debt securities
5,308

103

 
7,602

 
(5,975
)
 
 
(1,882
)
764

5,920

 
466

 
Loans
10,787

665

 
10,411

 
(7,431
)
 
 
(685
)
(292
)
13,455

 
315

 
Asset-backed securities
3,696

191

 
1,912

 
(2,379
)
 
 
(292
)
(1,856
)
1,272

 
105

 
Total debt instruments
23,662

1,724

 
24,286

 
(20,446
)
 
 
(3,612
)
(1,279
)
24,335

 
1,304

 
Equity securities
1,092

(37
)
 
328

 
(266
)
 
 
(135
)
(115
)
867

 
46

 
Physical commodities

(4
)
 

 
(8
)
 
 

16

4

 
(4
)
 
Other
863

558

 
659

 
(95
)
 
 
(120
)
135

2,000

 
1,074

 
Total trading assets – debt and equity instruments
25,617

2,241

(c) 
25,273

 
(20,815
)
 
 
(3,867
)
(1,243
)
27,206

 
2,420

(c) 
Net derivative receivables:(a)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate
3,322

1,358

 
344

 
(220
)
 
 
(2,391
)
(34
)
2,379

 
107

 
Credit
1,873

(1,697
)
 
115

 
(12
)
 
 
(357
)
173

95

 
(1,449
)
 
Foreign exchange
(1,750
)
(101
)
 
3

 
(4
)
 
 
683

(31
)
(1,200
)
 
(110
)
 
Equity
(1,806
)
2,528

 
1,305

 
(2,111
)
 
 
(1,353
)
374

(1,063
)
 
872

 
Commodity
254

816

 
105

 
(3
)
 
 
(1,107
)
50

115

 
410

 
Total net derivative receivables
1,893

2,904

(c) 
1,872

 
(2,350
)
 
 
(4,525
)
532

326

 
(170
)
(c) 
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asset-backed securities
28,024

4

 
579

 
(57
)
 
 
(57
)
(27,405
)
1,088

 
4

 
Other
892

26

 
508

 
(216
)
 
 
(6
)
30

1,234

 
25

 
Total available-for-sale securities
28,916

30

(d) 
1,087

 
(273
)
 
 
(63
)
(27,375
)
2,322

 
29

(d) 
Loans
2,282

81

(c) 
1,065

 
(191
)
 
 
(1,306
)

1,931

 
(21
)
(c) 
Mortgage servicing rights
7,614

1,612

(e) 
2,215

 
(725
)
 
 
(1,102
)

9,614

 
1,612

(e) 
Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Private equity investments
5,590

824

(c) 
537

 
(1,080
)
 
 
140

(195
)
5,816

 
42

(c) 
All other
2,122

(17
)
(f) 
49

 
(427
)
 
 
(345
)

1,382

 
(64
)
(f) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value measurements using significant unobservable inputs
 
 
Year ended
December 31, 2013
(in millions)
Fair value at January 1, 2013
Total realized/unrealized (gains)/losses
 
 
 
 
 
 
Transfers into and/or out of level 3(i)
Fair value at Dec. 31, 2013
Change in unrealized (gains)/losses related to financial instruments held at Dec. 31, 2013
Purchases(g)
 
Sales
 
Issuances
Settlements(h)
Liabilities:(b)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Deposits
$
1,983

$
(82
)
(c) 
$

 
$

 
$
1,248

$
(222
)
$
(672
)
$
2,255

 
$
(88
)
(c) 
Other borrowed funds
1,619

(177
)
(c) 

 

 
7,108

(6,845
)
369

2,074

 
291

(c) 
Trading liabilities – debt and equity instruments
205

(83
)
(c) 
(2,418
)
 
2,594

 

(54
)
(131
)
113

 
(100
)
(c) 
Accounts payable and other liabilities


 

 

 




 

 
Beneficial interests issued by consolidated VIEs
925

174

(c) 

 

 
353

(212
)

1,240

 
167

(c) 
Long-term debt
8,476

(435
)
(c) 

 

 
6,830

(4,362
)
(501
)
10,008

 
(85
)
(c) 
Note: Effective April 1, 2015, the Firm adopted new accounting guidance for certain investments where the Firm measures fair value using the net asset value per share (or its equivalent) as a practical expedient and excluded such investments from the fair value hierarchy. The guidance was required to be applied retrospectively, and accordingly, prior period amounts have been revised to conform with the current period presentation. For further information, see page 190.
(a)
All level 3 derivatives are presented on a net basis, irrespective of underlying counterparty.
(b)
Level 3 liabilities as a percentage of total Firm liabilities accounted for at fair value (including liabilities measured at fair value on a nonrecurring basis) were 13%, 15% and 18% at December 31, 2015, 2014 and 2013, respectively.
(c)
Predominantly reported in principal transactions revenue, except for changes in fair value for CCB mortgage loans, lending-related commitments originated with the intent to sell, and mortgage loan purchase commitments, which are reported in mortgage fees and related income.
(d)
Realized gains/(losses) on AFS securities, as well as other-than-temporary impairment losses that are recorded in earnings, are reported in securities gains. Unrealized gains/(losses) are reported in OCI. Realized gains/(losses) and foreign exchange remeasurement adjustments recorded in income on AFS securities were $(7) million, $(43) million, and $17 million for the years ended December 31, 2015, 2014 and 2013, respectively. Unrealized gains/(losses) recorded on AFS securities in OCI were $(25) million, $(16) million and $13 million for the years ended December 31, 2015, 2014 and 2013, respectively.
(e)
Changes in fair value for CCB MSRs are reported in mortgage fees and related income.
(f)
Predominantly reported in other income.
(g)
Loan originations are included in purchases.
(h)
Includes financial assets and liabilities that have matured, been partially or fully repaid, impacts of modifications, and deconsolidations associated with beneficial interests in VIEs.
(i)
All transfers into and/or out of level 3 are assumed to occur at the beginning of the quarterly reporting period in which they occur.

Level 3 analysis
Consolidated balance sheets changes
Level 3 assets (including assets measured at fair value on a nonrecurring basis) were 1.4% of total Firm assets at December 31, 2015. The following describes significant changes to level 3 assets since December 31, 2014, for those items measured at fair value on a recurring basis. For further information on changes impacting items measured at fair value on a nonrecurring basis, see Assets and liabilities measured at fair value on a nonrecurring basis on pages 200–201.
For the year ended December 31, 2015
Level 3 assets were $31.2 billion at December 31, 2015, reflecting a decrease of $18.0 billion from December 31, 2014. This decrease was driven by settlements (including repayments and restructurings) and transfers to Level 2 due to an increase in observability and a decrease in the significance of unobservable inputs. In particular:
$10.6 billion decrease in trading assets — debt and equity instruments was driven by a decrease of $6.7 billion in trading loans due to sales, maturities and transfers from level 3 to level 2 as a result of an increase in observability of certain valuation inputs and a $2.3 billion decrease in corporate debt securities due to transfers from level 3 to level 2 as a result of an increase in observability of certain valuation inputs
$4.6 billion decrease in gross derivative receivables was driven by a $3.9 billion decrease in equity, interest rate and foreign exchange derivative receivables due to market movements and transfers from level 3 to level 2 as a result of an increase in observability of certain valuation inputs
Gains and losses
The following describes significant components of total realized/unrealized gains/(losses) for instruments measured at fair value on a recurring basis for the years ended December 31, 2015, 2014 and 2013. For further information on these instruments, see Changes in level 3 recurring fair value measurements rollforward tables on pages 195–199.
2015
$1.6 billion of net gains in interest rate, foreign exchange and equity derivative receivables largely due to market movements; partially offset by loss in commodity derivatives due to market movements
$1.3 billion of net gains in liabilities due to market movements
2014
$1.8 billion of losses on MSRs. For further discussion of the change, refer to Note 17
$1.1 billion of net gains on trading assets — debt and equity instruments, largely driven by market movements and client-driven financing transactions
2013
$2.9 billion of net gains on derivatives, largely driven by $2.5 billion of gains on equity derivatives, primarily related to client-driven market-making activity and a rise in equity markets; and $1.4 billion of gains, predominantly on interest rate lock and mortgage loan purchase commitments; partially offset by $1.7 billion of losses on credit derivatives from the impact of tightening reference entity credit spreads
$2.2 billion of net gains on trading assets — debt and equity instruments, largely driven by market making and credit spread tightening in nonagency mortgage-backed securities and trading loans, and the impact of market movements on client-driven financing transactions
$1.6 billion of net gains on MSRs. For further discussion of the change, refer to Note 17
Credit and funding adjustments
When determining the fair value of an instrument, it may be necessary to record adjustments to the Firm’s estimates of fair value in order to reflect counterparty credit quality, the Firm’s own creditworthiness, and the impact of funding:
CVA is taken to reflect the credit quality of a counterparty in the valuation of derivatives. Derivatives are generally valued using models that use as their basis observable market parameters. These market parameters may not consider counterparty non-performance risk. Therefore, an adjustment may be necessary to reflect the credit quality of each derivative counterparty to arrive at fair value.
The Firm estimates derivatives CVA using a scenario analysis to estimate the expected credit exposure across all of the Firm’s positions with each counterparty, and then estimates losses as a result of a counterparty credit event. The key inputs to this methodology are (i) the expected positive exposure to each counterparty based on a simulation that assumes the current population of existing derivatives with each counterparty remains unchanged and considers contractual factors designed to mitigate the Firm’s credit exposure, such as collateral and legal rights of offset; (ii) the probability of a default event occurring for each counterparty, as derived from observed or estimated CDS spreads; and (iii) estimated recovery rates implied by CDS, adjusted to consider the differences in recovery rates as a derivative creditor relative to those reflected in CDS spreads, which generally reflect senior unsecured creditor risk. As such, the Firm estimates derivatives CVA relative to the relevant benchmark interest rate.
DVA is taken to reflect the credit quality of the Firm in the valuation of liabilities measured at fair value. The DVA calculation methodology is generally consistent with the CVA methodology described above and incorporates JPMorgan Chase’s credit spreads as observed through the CDS market to estimate the probability of default and loss given default as a result of a systemic event affecting the Firm. Structured notes DVA is estimated using the current fair value of the structured note as the exposure amount, and is otherwise consistent with the derivative DVA methodology.
FVA is taken to incorporate the impact of funding in the Firm’s valuation estimates where there is evidence that a market participant in the principal market would incorporate it in a transfer of the instrument. For collateralized derivatives, the fair value is estimated by discounting expected future cash flows at the relevant overnight indexed swap (“OIS”) rate given the underlying collateral agreement with the counterparty. For uncollateralized (including partially collateralized) over-the-counter (“OTC”) derivatives and structured notes, effective in 2013, the Firm implemented a FVA framework to incorporate the impact of funding into its valuation estimates. The Firm’s FVA framework leverages its existing CVA and DVA calculation methodologies, and considers the fact that the Firm’s own credit risk is a significant component of funding costs. The key inputs to FVA are: (i) the expected funding requirements arising from the Firm’s positions with each counterparty and collateral arrangements; (ii) for assets, the estimated market funding cost in the principal market; and (iii) for liabilities, the hypothetical market funding cost for a transfer to a market participant with a similar credit standing as the Firm.
Upon the implementation of the FVA framework in 2013, the Firm recorded a one-time $1.5 billion loss in principal transactions revenue that was recorded in the CIB. While the FVA framework applies to both assets and liabilities, the loss on implementation largely related to uncollateralized derivative receivables given that the impact of the Firm’s own credit risk, which is a significant component of funding costs, was already incorporated in the valuation of liabilities through the application of DVA.
The following table provides the impact of credit and funding adjustments on principal transactions revenue in the respective periods, excluding the effect of any associated hedging activities. The DVA and FVA reported below include the impact of the Firm’s own credit quality on the inception value of liabilities as well as the impact of changes in the Firm’s own credit quality over time.
Year ended December 31,
(in millions)
2015
 
2014
 
2013
Credit adjustments:
 
 
 
 
 
Derivatives CVA
$
620

 
$
(322
)
 
$
1,886

Derivatives DVA and FVA(a)
73

 
(58
)
 
(1,152
)
Structured notes DVA and FVA(b)
754

 
200

 
(760
)
(a)
Included derivatives DVA of $(6) million, $(1) million and $(115) million for the years ended December 31, 2015, 2014 and 2013, respectively.
(b)
Included structured notes DVA of $171 million, $20 million and $(337) million for the years ended December 31, 2015, 2014 and 2013, respectively.

Assets and liabilities measured at fair value on a nonrecurring basis
At December 31, 2015 and 2014, assets measured at fair value on a nonrecurring basis were $1.7 billion and $4.5 billion, respectively, consisting predominantly of loans that had fair value adjustments for the years ended December 31, 2015 and 2014. At December 31, 2015, $696 million and $959 million of these assets were classified in levels 2 and 3 of the fair value hierarchy, respectively. At December 31, 2014, $1.3 billion and $3.2 billion of these assets were classified in levels 2 and 3 of the fair value hierarchy, respectively. Liabilities measured at fair value on a nonrecurring basis were not significant at December 31, 2015 and 2014. For the years ended December 31, 2015, 2014 and 2013, there were no significant transfers between levels 1, 2 and 3 related to assets held at the balance sheet date.
Of the $959 million in level 3 assets measured at fair value on a nonrecurring basis as of December 31, 2015:
$556 million related to residential real estate loans carried at the net realizable value of the underlying collateral (i.e., collateral-dependent loans and other loans charged off in accordance with regulatory guidance). These amounts are classified as level 3, as they are valued using a broker’s price opinion and discounted based upon the Firm’s experience with actual liquidation values. These discounts to the broker price opinions ranged from 4% to 59%, with a weighted average of 22%.
The total change in the recorded value of assets and liabilities for which a fair value adjustment has been included in the Consolidated statements of income for the years ended December 31, 2015, 2014 and 2013, related to financial instruments held at those dates, were losses of $294 million, $992 million and $789 million, respectively; these reductions were predominantly associated with loans.
For further information about the measurement of impaired collateral-dependent loans, and other loans where the carrying value is based on the fair value of the underlying collateral (e.g., residential mortgage loans charged off in accordance with regulatory guidance), see Note 14.
Additional disclosures about the fair value of financial instruments that are not carried on the Consolidated balance sheets at fair value
U.S. GAAP requires disclosure of the estimated fair value of certain financial instruments, and the methods and significant assumptions used to estimate their fair value. Financial instruments within the scope of these disclosure requirements are included in the following table. However, certain financial instruments and all nonfinancial instruments are excluded from the scope of these disclosure requirements. Accordingly, the fair value disclosures provided in the following table include only a partial estimate of the fair value of JPMorgan Chase’s assets and liabilities. For example, the Firm has developed long-term relationships with its customers through its deposit base and credit card accounts, commonly referred to as core deposit intangibles and credit card relationships. In the opinion of management, these items, in the aggregate, add significant value to JPMorgan Chase, but their fair value is not disclosed in this Note.
Financial instruments for which carrying value approximates fair value
Certain financial instruments that are not carried at fair value on the Consolidated balance sheets are carried at amounts that approximate fair value, due to their short-term nature and generally negligible credit risk. These instruments include cash and due from banks, deposits with banks, federal funds sold, securities purchased under resale agreements and securities borrowed, short-term receivables and accrued interest receivable, commercial paper, federal funds purchased, securities loaned and sold under repurchase agreements, other borrowed funds, accounts payable, and accrued liabilities. In addition, U.S. GAAP requires that the fair value of deposit liabilities with no stated maturity (i.e., demand, savings and certain money market deposits) be equal to their carrying value; recognition of the inherent funding value of these instruments is not permitted.
The following table presents by fair value hierarchy classification the carrying values and estimated fair values at December 31, 2015 and 2014, of financial assets and liabilities, excluding financial instruments which are carried at fair value on a recurring basis. For additional information regarding the financial instruments within the scope of this disclosure, and the methods and significant assumptions used to estimate their fair value, see pages 185–188 of this Note.
 
December 31, 2015
 
December 31, 2014
 
 
Estimated fair value hierarchy
 
 
 
Estimated fair value hierarchy
 
(in billions)
Carrying
value
Level 1
Level 2
Level 3
Total estimated
fair value
 
Carrying
value
Level 1
Level 2
Level 3
Total estimated
fair value
Financial assets
 
 
 
 
 
 
 
 
 
 
 
Cash and due from banks
$
20.5

$
20.5

$

$

$
20.5

 
$
27.8

$
27.8

$

$

$
27.8

Deposits with banks
340.0

335.9

4.1


340.0

 
484.5

480.4

4.1


484.5

Accrued interest and accounts receivable
46.6


46.4

0.2

46.6

 
70.1


70.0

0.1

70.1

Federal funds sold and securities purchased under resale agreements
189.5


189.5


189.5

 
187.2


187.2


187.2

Securities borrowed
98.3


98.3


98.3

 
109.4


109.4


109.4

Securities, held-to-maturity(a)
49.1


50.6


50.6

 
49.3


51.2


51.2

Loans, net of allowance for loan losses(b)
820.8


25.4

802.7

828.1

 
740.5


21.8

723.1

744.9

Other
66.0

0.1

56.3

14.3

70.7

 
64.7


55.7

13.3

69.0

Financial liabilities
 
 
 
 
 
 
 
 
 
 
 
Deposits
$
1,267.2

$

$
1,266.1

$
1.2

$
1,267.3

 
$
1,354.6

$

$
1,353.6

$
1.2

$
1,354.8

Federal funds purchased and securities loaned or sold under repurchase agreements
149.2


149.2


149.2

 
189.1


189.1


189.1

Commercial paper
15.6


15.6


15.6

 
66.3


66.3


66.3

Other borrowed funds
11.2


11.2


11.2

 
15.5



15.5


15.5

Accounts payable and other liabilities(c)
144.6


141.7

2.8

144.5

 
172.6


169.6

2.9

172.5

Beneficial interests issued by consolidated VIEs(d)
41.1


40.2

0.9

41.1

 
50.2


48.2

2.0

50.2

Long-term debt and junior subordinated deferrable interest debentures(e)
255.6


257.4

4.3

261.7

 
246.2


251.2

3.8

255.0

(a)
Carrying value reflects unamortized discount or premium.
(b)
Fair value is typically estimated using a discounted cash flow model that incorporates the characteristics of the underlying loans (including principal, contractual interest rate and contractual fees) and other key inputs, including expected lifetime credit losses, interest rates, prepayment rates, and primary origination or secondary market spreads. For certain loans, the fair value is measured based on the value of the underlying collateral. The difference between the estimated fair value and carrying value of a financial asset or liability is the result of the different methodologies used to determine fair value as compared with carrying value. For example, credit losses are estimated for a financial asset’s remaining life in a fair value calculation but are estimated for a loss emergence period in the allowance for loan loss calculation; future loan income (interest and fees) is incorporated in a fair value calculation but is generally not considered in the allowance for loan losses. For a further discussion of the Firm’s methodologies for estimating the fair value of loans and lending-related commitments, see Valuation hierarchy on pages 185–188.
(c)
Certain prior period amounts have been revised to conform with the current presentation.
(d)
Carrying value reflects unamortized issuance costs.
(e)
Carrying value reflects unamortized premiums and discounts, issuance costs, and other valuation adjustments.
The majority of the Firm’s lending-related commitments are not carried at fair value on a recurring basis on the Consolidated balance sheets, nor are they actively traded. The carrying value of the allowance and the estimated fair value of the Firm’s wholesale lending-related commitments were as follows for the periods indicated.
 
December 31, 2015
 
December 31, 2014
 
 
Estimated fair value hierarchy
 
 
 
Estimated fair value hierarchy
 
(in billions)
Carrying value(a)
Level 1
Level 2
Level 3
Total estimated fair value
 
Carrying value(a)
Level 1
Level 2
Level 3
Total estimated fair value
Wholesale lending-related commitments
$
0.8

$

$

$
3.0

$
3.0

 
$
0.6

$

$

$
1.6

$
1.6

(a)
Excludes the current carrying values of the guarantee liability and the offsetting asset, each of which are recognized at fair value at the inception of guarantees.

The Firm does not estimate the fair value of consumer lending-related commitments. In many cases, the Firm can reduce or cancel these commitments by providing the borrower notice or, in some cases as permitted by law, without notice. For a further discussion of the valuation of lending-related commitments, see page 186 of this Note.